BlackRock Inc. - UNICYCIVE THERAPEUTICS INC ownership

UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 16 filers reported holding UNICYCIVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of UNICYCIVE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$31,000
-6.1%
24,166
+50.6%
0.00%
Q4 2021$33,0000.0%16,045
+40.2%
0.00%
Q3 2021$33,00011,4430.00%
Other shareholders
UNICYCIVE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ayrton Capital LLC 76,645$64,0000.10%
Nantahala Capital Management 729,680$606,0000.03%
Board of Trustees of The Leland Stanford Junior University 247,583$205,0000.01%
TANDEM CAPITAL MANAGEMENT CORP /ADV 15,500$13,0000.01%
FineMark National Bank & Trust 15,625$13,0000.00%
Frontier Wealth Management LLC 18,800$16,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 26,109$21,0000.00%
Citadel Advisors 15,210$13,0000.00%
Tower Research Capital LLC (TRC) 5,167$4,0000.00%
View complete list of UNICYCIVE THERAPEUTICS INC shareholders